Close

Dallas Fort Worth Injury Lawyer Blog

Updated:

Texas DePuy Attorney Warns About Pinnacle Hip Lawsuits

According to experts, Johnson & Johnson, the parent company of DePuy Orthopaedics, is facing more than 4,000 lawsuits over the DePuy Pinnacle hip device. The 4,000 plus plaintiffs, allege that the DePuy Pinnacle metal-on-metal design is defective and prone to premature failure and metallosis caused by the release of metal…

Updated:

Byetta, Januvia & Victoza Pancreatic Cancer Risk

Recent medical research suggests that certain type 2 diabetic medications, known as Incretin Mimetics, including Januvia, Janumet, Byetta, Bydureon and Victoza, are potentially linked to an increased risk of pancreatic cancer side effects when compared to other diabetes treatment. Incretin Mimetic Investigation Timeline April 18, 2013 – Institute for Safe…

Updated:

New Report: Pancreatic Cancer Risk from Byetta, Januvia, Victoza

According to the Institute for Safe Medication Practices (ISMP)’s Quarter Watch report, the number of pancreatic cancer cases are increasing involving lethal side effects of Byetta, Januvia, Victoza and other diabetes drugs known as incretin mimetics. ISMP evaluates adverse event reports submitted to the FDA, and the report, Perspectives on…

Updated:

Januvia, Janumet, Byetta, Victoza Heading to Federal MDL

The U.S. Judicial Panel on Multidistrict Litigation (JPML) has received a request to consolidate all federal pancreatic cancer lawsuits. These were filed by patients using Januvia, Janumet, Byetta and Victoza incretin mimetic diabetic drugs and they allege that they developed pancreatic cancer. The injured pancreatic cancer plaintiffs have requested that…

Contact Us
Start Chat